IKKε was first described as an oncogene in breast cancer [26,27] and is often overexpressed in a variety of cancers, including ovarian, lung, pancreatic and prostate cancers [10,12,16,28,29,30,31]. Here, IKBKE is linked to prostate carcinoma.